Recent Progress of Induced Pluripotent Stem Cells in Alzheimer’s Disease
DOI:
Author:
Affiliation:

School of Medicine, Ningbo University,The No.2 Hospital of Ningbo,School of Medicine, Ningbo University,School of Medicine, Ningbo University,School of Medicine, Ningbo University

Clc Number:

Fund Project:

This work was supported by grants from The National Natural Science Foundation of China (81771166, 81471398), Natural Science Foundation of Zhejiang Province (LY16H090001), Natural Science Foundation of Ningbo (2015A610211), Ningbo Municipal Innovation Team of Life Science and Health (2015C110026), and the K.C.Wong Magna Fund in Ningbo University

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Alzheimer’s disease (AD) is a complex multifactorial disease, characterized by progressive cognitive impairments and loss of memory. At present, there is no effective treatment for AD. The neurons differentiated from induced pluripotent stem cells (iPSCs) which are derived from AD patients have the relevant pathological manifestations of AD. Thus iPSCs is one of models for the study of the pathogenesis of AD and for finding the underlying drug target for AD. iPSCs can differentiate into different types of nerve cells to improve the symptoms of AD. The study of iPSCs in AD became an important issue. The advantages of iPSCs as a model in the pathological study of AD and the role of iPSCs in AD treatment were summarized in this article.

    Reference
    Related
    Cited by
Get Citation

WANG Yuan-Yuan, BAO Xiao-Ming, LING Yun-Xiang, WANG Qin-Wen, XU Shu-Jun. Recent Progress of Induced Pluripotent Stem Cells in Alzheimer’s Disease[J]. Progress in Biochemistry and Biophysics,2018,45(6):637-643

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 16,2017
  • Revised:March 02,2018
  • Accepted:March 06,2018
  • Online: June 20,2018
  • Published: June 20,2018